NCT05687266 · Interventional trial
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
Overall registry status Active not recruiting
Phase 3
Conditions NSCLC
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
- Research Site · Philadelphia, PA · Philadelphia County
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory